Thu Ho
Pediatric Endocrinology · San Jose, CANPI 1245437433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations.
Across 237 payments — averaging $22.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$681
- Novo Nordisk$553
- Xeris Pharmaceuticals, Inc.$537
- IBSA Pharma Inc.$528
- Amgen$519
- Sanofi-aventis U.S. LLC$472
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,37099%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 51 | $681 |
| Novo Nordisk | 18 | $553 |
| Xeris Pharmaceuticals, Inc. | 29 | $537 |
| IBSA Pharma Inc. | 15 | $528 |
| Amgen(2 entities) | 20 | $519 |
| Sanofi-aventis U.S. LLC | 13 | $472 |
| Lilly USA, LLC | 13 | $341 |
| AstraZeneca(2 entities) | 12 | $328 |
| AbbVie | 11 | $195 |
| Abbott | 9 | $183 |
| Mannkind Corporation | 5 | $182 |
| Pfizer | 7 | $148 |
| Dexcom, Inc. | 5 | $109 |
| Ascensia Diabetes Care US Inc. | 4 | $94 |
| Tandem Diabetes Care, Inc. | 4 | $86 |
| Tolmar Pharmaceuticals, Inc. | 3 | $81 |
| Recordati_rare_diseases_inc. | 3 | $66 |
| Companion Medical, Inc. | 2 | $36 |
| Insulet Corporation | 2 | $33 |
| UCB, Inc. | 1 | $32 |
| Merck | 2 | $32 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Almatica Pharma LLC | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Bayer | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,412 in reported general payments places this provider in the 80th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in San Jose
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
- Stephen GitelmanSan Francisco$105K
- David MaahsStanford$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.